Gentian Diagnostics AS - Primary insider notification

Following the share purchase, Vatne Equity AS will hold 1,735,340 shares in Gentian, corresponding to 11.27% of the outstanding shares. In addition, Lioness AS, a sister company of Vatne Equity AS, owns 150,000 shares in Gentian, corresponding to 0.97% of the outstanding shares. Following the share purchase, Vatne Equity AS and Lioness AS will together hold 1,885,340 shares in Gentian, corresponding to 12.25% of the outstanding shares.

This information is subject to the disclosure requirements set out in section 5-12 of the Norwegian Securities Trading Act.

Further information
Henrik Krefting
Chief Executive Officer, Vatne Capital AS
E-mail: hk@vatnecapital.com Cell Phone: +47 916 12 279